HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

First two successful unrelated donor bone marrow transplantations for paroxysmal nocturnal hemoglobinuria in Poland.

AbstractOBJECTIVES:
The experience with bone marrow transplantation (BMT) from matched unrelated donors (MUD) for paroxysmal nocturnal hemoglobinuria (PNH) is limited and optimal preparative regimen has been not established.
METHODS:
We report first two MUD BMTs for patients with PNH in Poland. Preparative regimen consisted of Treosulfan, Fludarabine and Thymoglobulin. We also present the review of published reports on allogeneic transplantations for PNH and discuss important transplant-related issues.
RESULTS:
Both patients are alive and are doing well over 12 and over 4 months following BMT. Regeneration is complete with full 100% donor chimerism and the eradication of PNH clone.
CONCLUSIONS:
MUD BMT is an effective treatment for PNH. Treosulfan, Fludarabine and Thymoglobulin treatment can be safely and effectively used for conditioning in PNH.
AuthorsMirosław Markiewicz, Maria Wojciechowska, Iwona Wylezoł, Sebastian Giebel, Krzysztof Woźniczka, Jerzy Wojnar, Ewa Mendek-Czajkowska, Jerzy Hołowiecki
JournalAnnals of transplantation (Ann Transplant) Vol. 10 Issue 3 Pg. 26-30 ( 2005) ISSN: 1425-9524 [Print] United States
PMID16617663 (Publication Type: Case Reports, Journal Article)
Topics
  • Adult
  • Bone Marrow Transplantation
  • Female
  • Hemoglobinuria, Paroxysmal (surgery)
  • Humans
  • Immunosuppression Therapy
  • Male
  • Poland
  • Transplantation Conditioning
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: